RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. BMO Capital Partners
B

BMO Capital Partners portfolio

BMO Capital Partners has 2 portfolio companies on record at Recent Funding.

Website: bmo.com.
Type: Corporate venture.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $96.8M.
Latest deal: Nanoprecise · Mar 27, 2025.
About this page

It is a corporate venture investor based in Toronto, Ontario, US, founded in 1817. Its most recent investment on record is Nanoprecise's $38M Series B+ round in March 2025, alongside Business Development Bank of Canada, Yaletown Partners and Export Development Canada. By category, its portfolio leans toward Data and analytics (1) and Manufacturing and industrial (1). It has co-invested with Business Development Bank of Canada, Export Development Canada and Yaletown Partners.

About BMO Capital Partners

Firm type: Corporate venture.
Headquarters: Toronto, Ontario, US.
Founded: 1817.
Stages: Series B.
Sectors: Sector Agnostic.

What BMO Capital Partners invests in

How BMO Capital Partners invests

StageDealsCapital in rounds
Series B+ 2 100%$96.8M
YearDealsCapital in rounds
2022 1 50%$58.8M
2025 1 50%$38M

BMO Capital Partners portfolio companies

CompanyRound with BMO Capital PartnersTotal raisedLatest raise
NNanoprecise
Data and analytics
Series B+ · $38M$47.99MMar 27, 2025
Series B+
NNesto
Lending and credit
Series B+ · $58.8M$237MJun 10, 2026
Series B+

Most frequent co-investors

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name BMO Capital Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists BMO Capital Partners, which is a subset of its real portfolio. API: /api/v1/investors/bmo-capital-partners (get a free API key). More: the most active VC firms and new venture capital funds.